256 related articles for article (PubMed ID: 27272726)
1. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
[TBL] [Abstract][Full Text] [Related]
2. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
3. A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase.
Yuan S; Chu H; Singh K; Zhao H; Zhang K; Kao RY; Chow BK; Zhou J; Zheng BJ
Sci Rep; 2016 Mar; 6():22880. PubMed ID: 26956222
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
[TBL] [Abstract][Full Text] [Related]
5. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
[TBL] [Abstract][Full Text] [Related]
6. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin is a new inhibitor of influenza polymerase PB2 subunit and influenza-induced inflammation.
Tian Y; Sang H; Liu M; Chen F; Huang Y; Li L; Liu S; Yang J
Microbes Infect; 2020; 22(6-7):254-262. PubMed ID: 32554102
[TBL] [Abstract][Full Text] [Related]
8. Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication.
Huang Q; Zhong Y; Li J; Ye Y; Wu W; Chen L; Feng M; Yang J; Liu S
Biochem Biophys Res Commun; 2020 Jun; 526(4):1143-1149. PubMed ID: 32327257
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir.
Patel MC; Chesnokov A; Jones J; Mishin VP; De La Cruz JA; Nguyen HT; Zanders N; Wentworth DE; Davis TC; Gubareva LV
Antiviral Res; 2021 Apr; 188():105035. PubMed ID: 33581212
[TBL] [Abstract][Full Text] [Related]
11. Peptide-Mediated Interference of PB2-eIF4G1 Interaction Inhibits Influenza A Viruses' Replication in Vitro and in Vivo.
Yuan S; Chu H; Ye J; Hu M; Singh K; Chow BK; Zhou J; Zheng BJ
ACS Infect Dis; 2016 Jul; 2(7):471-7. PubMed ID: 27626099
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.
Liu Y; Qin K; Meng G; Zhang J; Zhou J; Zhao G; Luo M; Zheng X
J Biol Chem; 2013 Apr; 288(16):11013-23. PubMed ID: 23436652
[TBL] [Abstract][Full Text] [Related]
14. The cap-binding site of influenza virus protein PB2 as a drug target.
Severin C; Rocha de Moura T; Liu Y; Li K; Zheng X; Luo M
Acta Crystallogr D Struct Biol; 2016 Feb; 72(Pt 2):245-53. PubMed ID: 26894672
[TBL] [Abstract][Full Text] [Related]
15. Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening.
Liu M; Lo CY; Wang G; Chow HF; Ngo JC; Wan DC; Poon LL; Shaw PC
Antiviral Res; 2017 Aug; 144():186-195. PubMed ID: 28629986
[TBL] [Abstract][Full Text] [Related]
16. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
[TBL] [Abstract][Full Text] [Related]
18. Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.
Hsu JT; Yeh JY; Lin TJ; Li ML; Wu MS; Hsieh CF; Chou YC; Tang WF; Lau KS; Hung HC; Fang MY; Ko S; Hsieh HP; Horng JT
Antimicrob Agents Chemother; 2012 Feb; 56(2):647-57. PubMed ID: 21930871
[TBL] [Abstract][Full Text] [Related]
19. Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors.
Tsai AW; McNeil CF; Leeman JR; Bennett HB; Nti-Addae K; Huang C; Germann UA; Byrn RA; Berlioz-Seux F; Rijnbrand R; Clark MP; Charifson PS; Jones SM
Antimicrob Agents Chemother; 2015 Oct; 59(10):6007-16. PubMed ID: 26169418
[TBL] [Abstract][Full Text] [Related]
20. New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.
Pautus S; Sehr P; Lewis J; Fortuné A; Wolkerstorfer A; Szolar O; Guilligay D; Lunardi T; Décout JL; Cusack S
J Med Chem; 2013 Nov; 56(21):8915-30. PubMed ID: 24134208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
